• Evaluating Drug-Induced Cell Death: Insights from In Vitro M

  2026-08-04

  Schwartz's dissertation offers a rigorous analysis of in vitro methods for distinguishing between drug-induced cell proliferation arrest and cell death in cancer models. By dissecting the limitations of conventional viability assays and proposing refined measurement frameworks, this work has substantial implications for translational research and drug development workflows.

• Aconitase Activity Colorimetric Assay Kit: Precision in TCA

  2026-08-04

  The Aconitase Activity Colorimetric Assay Kit from APExBIO empowers researchers to quantify mitochondrial aconitase activity with rapid, high-sensitivity colorimetric detection. Its robust workflow enables actionable insights into oxidative damage and metabolic reprogramming, particularly within immunometabolic and cancer research settings.

• Sisomicin in Precision Antibacterial Assays: Mechanisms & Ev

  2026-08-03

  Explore the scientific foundations and advanced applications of Sisomicin, a broad-spectrum aminoglycoside antibiotic, in antibacterial assay development. This article delivers mechanistic insights, practical protocol guidance, and unique evidence-based perspectives for researchers targeting Gram-negative and Gram-positive pathogens.

• ARCA Cy5 EGFP mRNA (5-moUTP): Unveiling Single-Cell Dynamics

  2026-08-03

  Explore the scientific depth of ARCA Cy5 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA for advanced mRNA localization and translation efficiency assays. Discover how its unique design empowers single-cell and spatiotemporal analysis beyond conventional tools.

• Adiponectin Reduces Post-Splenectomy Cognitive Deficits via

  2026-08-02

  This study reveals that adiponectin treatment alleviates neuroinflammation and oxidative stress to improve cognitive function following splenectomy in aged rats, primarily through inhibition of the TLR4/MyD88/NF-κB signaling pathway. The findings highlight a mechanistic link between adiponectin signaling and perioperative neurocognitive disorder and suggest protocol strategies for preclinical models of neuroimmune dysfunction.

• IR-820 (New Indocyanine Green): Foundation of In Vivo Imagin

  2026-08-01

  Explore how IR-820 (New Indocyanine Green) is redefining in vivo imaging through its unique photophysical properties and protocol-critical parameters. This guide reveals mechanistic insights, advanced applications, and evidence-based workflow recommendations beyond standard imaging guides.

• 5-Azacytidine in Multiple Myeloma: Mechanistic Insights and

  2026-07-31

  Explore the multifaceted role of 5-Azacytidine as a DNA demethylation agent in multiple myeloma research. This article unveils new mechanistic evidence and practical protocol guidance, offering a distinct perspective beyond standard reviews.

• 5-Azacytidine-Induced Dormancy Suppresses Metastatic Outgrow

  2026-07-31

  Singh et al. (2023) demonstrate that 5-Azacytidine, combined with retinoic acid, robustly reprograms disseminated cancer cells into a dormant state and suppresses metastasis by restoring TGF-β–SMAD4 signaling. These findings highlight a mechanistically distinct, actionable pathway for preventing metastatic progression in cancer models.

• Strategic Viability Analysis in CD38 CAR-T Research: Mechani

  2026-07-30

  This thought-leadership article explores the mechanistic and translational implications of reliable cell viability assessment in advanced immunotherapy workflows. Drawing on recent structural studies of CD38-targeted CAR binders and the unique advantages of the 7-AAD Cell Viability Assay Kit, it provides strategic guidance for translational researchers seeking to optimize workflow precision, minimize experimental drift, and accelerate clinical impact in cell therapy research.

• Nile Red for Lipid Storage Dynamics: Protocols and Pitfalls

  2026-07-30

  Nile Red (Nile blue oxazone) empowers precise, selective intracellular lipid droplet staining with dual-emission capabilities. This guide delivers workflow enhancements, troubleshooting strategies, and evidence-backed insights for optimizing lipid metabolism research.

• 7-AAD Cell Viability Assay Kit: Precision in Necrosis Detect

  2026-07-29

  The 7-AAD Cell Viability Assay Kit empowers researchers with accurate, multiplexed detection of necrosis and apoptosis, especially in high-stakes CAR-T and immunotherapy workflows. Its superior spectral properties and robust compatibility with flow cytometry and fluorescence microscopy set it apart from traditional viability assays.

• Belinostat (PXD101): Applied Protocols for Epigenetic Cancer

  2026-07-29

  Belinostat (PXD101) empowers precision epigenetic modulation for cancer researchers, offering nanomolar pan-HDAC inhibition and robust reproducibility across bladder and prostate cancer models. This guide delivers actionable protocols, troubleshooting insights, and a translation of advanced in vitro evaluation methods for optimal experimental outcomes.

• Optimizing Cardiovascular Assays with Atrial Natriuretic Pep

  2026-07-28

  Discover how 'Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat' (SKU A1009) enhances reproducibility and sensitivity in cardiovascular and cell viability assays. This scenario-driven article equips biomedical researchers and lab technicians with evidence-based guidance, revealing how APExBIO’s high-purity ANP streamlines workflows and supports robust data generation.

• PD 173074 (SKU A8253): Practical Guidance for FGFR1/VEGFR2 I

  2026-07-28

  This article delivers scenario-driven, evidence-based insights into using PD 173074 (SKU A8253) for robust FGFR signaling pathway inhibition in cancer research. It addresses real-world assay reproducibility, protocol optimization, and data interpretation challenges, guiding bench scientists to reliable experimental outcomes. Discover how PD 173074 from APExBIO meets the demands of modern cell-based and in vivo workflows.

• Disulfiram: Dopamine β-Hydroxylase Inhibitor for Cancer Rese

  2026-07-27

  Disulfiram's dual role as a dopamine β-hydroxylase inhibitor and proteasome modulator enables advanced synthetic lethality and apoptosis workflows, particularly in cancer research targeting APC-deficient tumors. APExBIO's Disulfiram product supports robust, reproducible experimental designs with well-defined solubility and dosing parameters.

16242 records 1/1083 page Next 12345 下5页 Last page